Inactivated Vaccines Market Poised for Robust Growth Amid Rising Immunization Demand 2025 | Major key players - GSK plc., Sanofi., Biological E Limited., Bharat Biotech.

Market Size and Growth:

The Global Inactivated Vaccines Market Size reached US$22.60 billion in 2024 and is expected to reach US$34.26 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2024-2032.

The Inactivated Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Inactivated Vaccines market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/inactivated-vaccines-market?sz

The Inactivated Vaccines Market encompasses the development, production, and distribution of vaccines containing viruses or bacteria that have been killed or inactivated. These vaccines stimulate the immune system without causing disease, offering protection against infections such as influenza, polio, and hepatitis. Market growth is driven by rising infectious diseases, government immunization programs, and technological advancements in vaccine formulation.

Key Developments of USA and Japan:

USA:

Public-Private Partnership: The U.S. Department of Health and Human Services (HHS) and the National Institutes of Health (NIH) launched the "Generation Gold Standard" initiative to develop a new, government-owned, beta-propiolactone (BPL)-inactivated, whole-virus vaccine platform for pandemic preparedness. This platform is designed to offer broad-spectrum protection against various strains of viruses like influenza and coronaviruses.

Vaccine Approvals and Recommendations: The FDA approved updated COVID-19 vaccines for the 2025-2026 season. The Advisory Committee on Immunization Practices (ACIP) also made recommendations for the use of new vaccines, including a new RSV vaccine (clesrovimab) for infants and an expanded age range for a meningococcal vaccine.

Japan:

Flu Vaccine Research: The University of Tokyo received government funding for a project to develop a "singly replicating" inactivated vaccine against seasonal influenza. This new type of vaccine is designed to elicit a strong immune response by producing viral antigens within cells.

Pediatric Immunization: The Japan Pediatric Society released updated recommendations for the 2025 immunization schedule, including the use of an inactivated influenza vaccine for children during the 2024/2025 season. A study showed that inactivated influenza vaccines were effective in children, supporting their continued use.

Key Players:

Serum Institute of India Pvt. Ltd.
GSK plc.
Sanofi.
Biological E Limited.
Bharat Biotech.
Bio Farma
Merck & Co., Inc.
Valneva SE.
Pfizer Inc.

KM Biologics

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=inactivated-vaccines-market

Market Segmentation:

By Pathogen: Bacteria, Virus.

By Vaccine Type: Polio Vaccine, DTaP Vaccine, Influenza Vaccine, Hepatitis Vaccine, Japanese Encephalitis Vaccine, Rabies Vaccine, Cholera Vaccine, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/inactivated-vaccines-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Inactivated Vaccines market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Inactivated Vaccines Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Inactivated Vaccines market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Inactivated Vaccines Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Inactivated Vaccines Market in 2025?
◆ What is the projected growth rate of the Inactivated Vaccines Market through 2033?
◆ Who are the key players in the Inactivated Vaccines Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.